211 related articles for article (PubMed ID: 15382088)
21. Identification of genes that are regulated transcriptionally by Myc in childhood tumors.
Raetz EA; Kim MK; Moos P; Carlson M; Bruggers C; Hooper DK; Foot L; Liu T; Seeger R; Carroll WL
Cancer; 2003 Aug; 98(4):841-53. PubMed ID: 12910530
[TBL] [Abstract][Full Text] [Related]
22. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region.
Zhang J; Chen S; Zhang W; Zhang J; Liu X; Shi H; Che H; Wang W; Li F; Yao L
Gene; 2008 Jul; 417(1-2):5-12. PubMed ID: 18455888
[TBL] [Abstract][Full Text] [Related]
23. Over-expression of transfected N-myc oncogene in human SKNSH neuroblastoma cells down-regulates expression of beta 1 integrin subunit.
Judware R; Culp LA
Oncogene; 1995 Dec; 11(12):2599-607. PubMed ID: 8545117
[TBL] [Abstract][Full Text] [Related]
24. The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl, c-Myc and HDAC3 in chronic myeloid leukemia cell lines.
Xu Y; Voelter-Mahlknecht S; Mahlknecht U
Int J Mol Med; 2005 Jan; 15(1):169-72. PubMed ID: 15583844
[TBL] [Abstract][Full Text] [Related]
25. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
Sekhavat A; Sun JM; Davie JR
Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
[TBL] [Abstract][Full Text] [Related]
26. Concomitant down-regulation of expression of integrin subunits by N-myc in human neuroblastoma cells: differential regulation of alpha2, alpha3 and beta1.
Judware R; Culp LA
Oncogene; 1997 Mar; 14(11):1341-50. PubMed ID: 9178894
[TBL] [Abstract][Full Text] [Related]
27. The circadian expression of c-MYC is modulated by the histone deacetylase inhibitor trichostatin A in synchronized murine neuroblastoma cells.
Repouskou A; Sourlingas TG; Sekeri-Pataryas KE; Prombona A
Chronobiol Int; 2010 Jun; 27(4):722-41. PubMed ID: 20560708
[TBL] [Abstract][Full Text] [Related]
28. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
29. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells.
Hernandez M; Shao Q; Yang XJ; Luh SP; Kandouz M; Batist G; Laird DW; Alaoui-Jamali MA
Prostate; 2006 Aug; 66(11):1151-61. PubMed ID: 16652385
[TBL] [Abstract][Full Text] [Related]
30. A novel MASH1 enhancer with N-myc and CREB-binding sites is active in neuroblastoma.
Watt F; Watanabe R; Yang W; Agren N; Arvidsson Y; Funa K
Cancer Gene Ther; 2007 Mar; 14(3):287-96. PubMed ID: 17124508
[TBL] [Abstract][Full Text] [Related]
31. Synergistic induction of DOC-2/DAB2 gene expression in transitional cell carcinoma in the presence of GATA6 and histone deacetylase inhibitor.
Zhou J; Hernandez G; Tu SW; Scholes J; Chen H; Tseng CP; Hsieh JT
Cancer Res; 2005 Jul; 65(14):6089-96. PubMed ID: 16024609
[TBL] [Abstract][Full Text] [Related]
32. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN
Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382
[TBL] [Abstract][Full Text] [Related]
33. [Mechanism of apoptosis induced by trichostatin A in leukemia Molt-4 cells analyzed by microarray].
Hong ZY; Yi LS; Miao XY; Lu YP; Zhou JF; Liu WL
Ai Zheng; 2006 Aug; 25(8):946-53. PubMed ID: 16965673
[TBL] [Abstract][Full Text] [Related]
34. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
[TBL] [Abstract][Full Text] [Related]
35. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.
Gao J; Chen T; Liu J; Liu W; Hu G; Guo X; Yin B; Gong Y; Zhao J; Qiang B; Yuan J; Peng X
Glia; 2009 Jul; 57(9):989-99. PubMed ID: 19062177
[TBL] [Abstract][Full Text] [Related]
36. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells.
Wang N; Lin KK; Lu Z; Lam KS; Newton R; Xu X; Yu Z; Gill GN; Andersen B
Oncogene; 2007 Sep; 26(44):6431-41. PubMed ID: 17452977
[TBL] [Abstract][Full Text] [Related]
37. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
38. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
Shohet JM; Hicks MJ; Plon SE; Burlingame SM; Stuart S; Chen SY; Brenner MK; Nuchtern JG
Cancer Res; 2002 Feb; 62(4):1123-8. PubMed ID: 11861392
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling in response to the histone deacetylase inhibitor BL1521 in neuroblastoma.
de Ruijter AJ; Meinsma RJ; Bosma P; Kemp S; Caron HN; van Kuilenburg AB
Exp Cell Res; 2005 Oct; 309(2):451-67. PubMed ID: 16084510
[TBL] [Abstract][Full Text] [Related]
40. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
